2017 RESEARCH

- Archives -

Former FDA commissioner Robert Califf presents Melvin S. Cutler lecture

Former FDA commissioner Robert Califf presents Melvin S. Cutler lecture

Robert M. Califf, MD, MACC, former commissioner of the Food and Drug Administration, presented the Melvin S. Cutler Lecture at UMass Medical School, entitled, “An American Approach to Medical Evidence Generation,” on Thursday, April 27.

UMMS researchers receive amfAR grant to eliminate HIV reservoirs using gene editing

UMMS researchers receive amfAR grant to eliminate HIV reservoirs using gene editing

Jeremy Luban, MD, and Scot Wolfe, PhD, have received a grant from amfAR to explore using a powerful gene editing tool, CRISPR/Cpf1, to eradicate the HIV genome in its host. The researchers are hoping that Cpf1’s unique capacity to employ multiple RNA “guides” will outmaneuver the retrovirus.

Flotte, colleagues call March for Science ‘first step’ in rebuilding public trust in research in Boston Globe editorial

Flotte, colleagues call March for Science ‘first step’ in rebuilding public trust in research in Boston Globe editorial

Tens of thousands of people are expected to flock to Washington, D.C., Boston and 400 other cities around the world for the April 22 March for Science, but UMass Medical School Dean Terence R. Flotte and his colleagues at Harvard Medical School, Tufts University School of Medicine and Boston University School of Medicine don’t want the fight for National Institutes of Health funding to stop there.

Ami Ashar-Patel named Keck Graduate Institute fellow

Ami Ashar-Patel named Keck Graduate Institute fellow

PhD candidate Ami Ashar-Patel has been selected to participate in the Keck Graduate Institute Certificate in Bioscience Management Program.

Examining the role of the microbiome in the effectiveness of colorectal cancer treatment

Examining the role of the microbiome in the effectiveness of colorectal cancer treatment

A study by Marian Walhout, PhD, and colleagues, shows that C. elegans, fed a diet of E.coli bacteria, are 100 times more sensitive to the chemotherapy drug floxuridine, commonly used to treat colon cancer, than worms fed different bacteria. These findings suggest that the bacteria residing in your digestive tract may play an important role in your ability to respond to chemotherapy. Results of the study were published in Cell

New study shows that antipsychotic medications can be reduced in dementia patients

New study shows that antipsychotic medications can be reduced in dementia patients

The use of antipsychotic medication in nearly 100 Massachusetts nursing homes was significantly reduced when staff members were trained to recognize challenging behaviors of cognitively impaired residents as communication of their unmet needs, according to a new study led by Jennifer Tjia, MD, MSCE.

UMass Medical School faculty appointed to endowed chairs

UMass Medical School faculty appointed to endowed chairs

UMass Medical School will invest three faculty members into newly endowed chairs and three more to existing endowed chairs, as approved by a vote of the UMass Board of Trustees at its April 12 meeting. Two of the newly funded chairs, to be held by Mark Johnson, MD, and Marian Walhout, PhD, were made possible through the generosity of Maroun Semaan, co-founder, director and president of Petrofac Group.

Job Dekker receives inaugural International Award from British Biochemical Society

Job Dekker receives inaugural International Award from British Biochemical Society

Job Dekker, PhD, has been recognized by the Biochemical Society, based in London, as the inaugural recipient of the International Award.

Telegram takes look inside ‘ballet of the cell’ through new cryo-EM technology at UMMS

Telegram takes look inside ‘ballet of the cell’ through new cryo-EM technology at UMMS

The Massachusetts Facility for High-Resolution Cryo-Electron Microscopy at UMass Medical School is giving scientists a front row seat to the “ballet of the cell,” according to Brian Kelch, PhD, assistant professor of biochemistry & molecular pharmacology, in an article published in the April 9 Worcester Telegram & Gazette.

John Landers explains science behind ALS gene discovery on WCVB-TV’s Chronicle

John Landers explains science behind ALS gene discovery on WCVB-TV’s Chronicle

UMass Medical School scientist John Landers, PhD, told WCVB-TV’s Chronicle host Erika Tarantal how his discovery of an ALS gene—research funded in part by the Ice Bucket Challenge—is making a difference in the quest for a cure.

Showing 1-10 of 35 items
of 4

Stay Connected with UMassMedNow

▴ Back To Top
Section Menu To Top